International Ophthalmology

, Volume 38, Issue 1, pp 175–181 | Cite as

A novel marker in acute central serous chorioretinopathy: thiol/disulfide homeostasis

  • Hasan Altinkaynak
  • Piraye Zeynep Kurkcuoglu
  • Mehtap Caglayan
  • Mücella Arıkan Yorgun
  • Nilay Yuksel
  • Pınar Kosekahya
  • Cemile Koca
  • Yasin Toklu
Original Paper
First Online:
Received:
Accepted:

Abstract

Purpose

The aim of this study was to compare dynamic thiol/disulfide homeostatic status in acute central serous chorioretinopathy (CSCR) patients by using a novel and automated assay determining dynamic thiol/disulfide homeostasis.

Methods

Fifty-one patients with acute CSCR (study group) and 65 healthy individuals (control group) were enrolled in this study. Diagnosis of acute CSCR was made clinically and using spectral-domain RTVue OCT (optical coherence tomography) (Optovue, Fremont, CA). Fluorescein angiography confirmed the diagnosis of acute CSCR in all subjects. Total thiol, native thiol, disulfide amount, and native thiol/disulfide ratio (TDR) were calculated in the blood samples.

Results

Mean total thiol, native thiol, and native TDR values were lower in patients with acute CSCR (364.2 ± 14.1, 326.4 ± 13.2, 17.14 ± 1.9, respectively) than in healthy eyes (441.2 ± 16.3, 398.5 ± 16.4, 22.70 ± 2.15, respectively; mean total thiol, p = 0.017; native thiol, p = 0.011; native TDR, p = 0.031).

Conclusions

Total thiol, native thiol, and native TDR were significantly lower statistically in patients with acute CSCR when compared with healthy controls.

Keywords

Central serous chorioretinopathy Total thiol Native thiol Thiol/disulfide ratio 
This is a preview of subscription content, log in to check access

Notes

Compliance with ethical standards

Conflict of interest

The authors declare no financial or proprietary interests.

Ethical approval

The study protocol followed the principles in the Declaration of Helsinki.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Tittl MK, Spaide RF, Wong D et al (1999) Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol 128:63–68CrossRefPubMedGoogle Scholar
  2. 2.
    Haimovici R, Koh S, Gagnon DR et al (2004) Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology 111:244–249CrossRefPubMedGoogle Scholar
  3. 3.
    Errera MH, Kohly RP, da Cruz L (2013) Pregnancy associated retinal diseases and their management. Surv Ophthalmol 58:127–142CrossRefPubMedGoogle Scholar
  4. 4.
    Casella AM, Berbel RF, Bressanim GL et al (2012) Helicobacter pylori as a potential target for the treatment of central serous chorioretinopathy. Clinics (Sao Paulo) 67:1047–1052CrossRefGoogle Scholar
  5. 5.
    Spahn C, Wiek J, Burger T et al (2003) Psychosomatic aspects in patients with central serous chorioretinopathy. Br J Ophthalmol 87:704–708CrossRefPubMedCentralPubMedGoogle Scholar
  6. 6.
    Fawzi AA, Holland GN, Kreiger AE et al (2006) Central serous chorioretinopathy after solid organ transplantation. Ophthalmology 113:805–813CrossRefPubMedGoogle Scholar
  7. 7.
    Gass JD (1997) Specific diseases causing disciform macular detachment. Stereosc Atlas of Macul Dis 1:52–87Google Scholar
  8. 8.
    Wang M, Munch IC, Hasler PW et al (2008) Central serous chorioretinopathy. Acta Ophthalmol 86:126–145CrossRefPubMedGoogle Scholar
  9. 9.
    Piccolino FC, Borgia L (1994) Central serous chorioretinopathy and indocyanine green angiography. Retina 14:231–242CrossRefPubMedGoogle Scholar
  10. 10.
    Prunte C, Flammer J (1996) Choroidal capillary and venous congestion in central serous retinopathy. Am J Ophthalmol 121:126–134CrossRefGoogle Scholar
  11. 11.
    Türkcü FM, Yüksel H, Yüksel H et al (2014) Serum dehydroepiandrosterone sulphate, total antioxidant capacity, and total oxidant status in central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 252(1):17–21CrossRefPubMedGoogle Scholar
  12. 12.
    Field MG, Elner VM, Park S et al (2000) Detection of retinal metabolic stress resulting from central serous retinopathy. Retina 29(8):1162–1166CrossRefGoogle Scholar
  13. 13.
    Guyer DR, Yannuzzi LA, Slakter JS et al (1994) Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol 112:1057–1062CrossRefPubMedGoogle Scholar
  14. 14.
    Sen CK, Packer L et al (2000) Thiol homeostasis and supplements in physical exercise. Am J Clin Nutr 72:653–669CrossRefGoogle Scholar
  15. 15.
    Turell L, Radi R, Alvarez B (2013) The thiol pool in human plasma: the central contribution of albumin to redox processes. Free Radic Biol Med 65:244–253CrossRefPubMedCentralPubMedGoogle Scholar
  16. 16.
    Cremers CM, Jakob U (2013) Oxidant sensing by reversible disulfide bond formation. J Biol Chem 288(37):26489–26496CrossRefPubMedCentralPubMedGoogle Scholar
  17. 17.
    Jones DP, Liang Y (2009) Measuring the poise of thiol/disulfide couples in vivo. Free Radic Biol Med 47(10):1329–1338CrossRefPubMedCentralPubMedGoogle Scholar
  18. 18.
    Biswas S, Chida AS, Rahman I (2006) Redox modifications of protein–thiols: emerging roles in cell signaling. Biochem Pharmacol 71(5):551–564CrossRefPubMedGoogle Scholar
  19. 19.
    Circu ML, Aw TY (2010) Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 48(6):749–762CrossRefPubMedCentralPubMedGoogle Scholar
  20. 20.
    Matteucci E, Giampietro O et al (2010) Thiol signalling network with an eye to diabetes. Molecules 15(12):8890–8903CrossRefPubMedGoogle Scholar
  21. 21.
    Go YM, Jones DP (2011) Cysteine/cystine redox signaling in cardiovascular disease. Free Radic Biol Med 50(4):495–509CrossRefPubMedGoogle Scholar
  22. 22.
    Prabhu A, Sarcar B, Kahali S et al (2014) Cysteine catabolism: a novel metabolic pathway contributing to glioblastoma growth. Cancer Res 74(3):787–796CrossRefPubMedGoogle Scholar
  23. 23.
    Tetik S, Ahmad S, Alturfan AA et al (2010) Determination of oxidant stress in plasma of rheumatoid arthritis and primary osteoarthritis patients. Indian J Biochem Biophys 47(6):353–358PubMedGoogle Scholar
  24. 24.
    Rodrigues SD, Batista GB, Ingberman M et al (2012) Plasma cysteine/cystine reduction potential correlates with plasma creatinine levels in chronic kidney disease. Blood Purif 34(3–4):231–237CrossRefPubMedGoogle Scholar
  25. 25.
    Sbrana E, Paladini A, Bramanti E et al (2004) Quantitation of reduced glutathione and cysteine in human immunodeficiency virus-infected patients. Electrophoresis 25(10–11):1522–1529CrossRefPubMedGoogle Scholar
  26. 26.
    Calabrese V, Lodi R, Tonon C et al (2005) Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich’s ataxia. J Neurol Sci 33(1–2):145–162CrossRefGoogle Scholar
  27. 27.
    Smeyne M, Smeyne RJ (2013) Glutathione metabolism and Parkinson’s disease. Free Radic Biol Med 62:13–25CrossRefPubMedCentralPubMedGoogle Scholar
  28. 28.
    Steele ML, Fuller S, Maczurek AE et al (2013) Chronic inflammation alters production and release of glutathione and related thiols in human U373 astroglial cells. Cell Mol Neurobiol 33(1):19–30CrossRefPubMedGoogle Scholar
  29. 29.
    Kuo LM, Kuo CY, Lin CY et al (2014) Intracellular glutathione depletion by oridonin leads to apoptosis in hepatic stellate cells. Molecules 19(3):3327–3344CrossRefPubMedGoogle Scholar
  30. 30.
    Erel O, Neselioglu S (2014) A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem 47:326–332CrossRefPubMedGoogle Scholar
  31. 31.
    Klais CM, Ober MD, Ciardella AP et al (2006) Central serous chorioretinopathy. In: Ryan SJ (ed) Retina, vol II, 4th edn. Mosby, St Louis, pp 1135–1161CrossRefGoogle Scholar
  32. 32.
    Piccolino FC, Eandi CM, Ventre L et al (2003) Photodynamic therapy for chronic central serous chorioretinopathy. Retina 23:752–763CrossRefGoogle Scholar
  33. 33.
    Taban M, Boyer DS, Thomas EL et al (2004) Chronic central serous chorioretinopathy: photodynamic therapy. Am J Ophthalmol 137:1073–1080CrossRefPubMedGoogle Scholar
  34. 34.
    Guyer DR, Yannuzzi LA, Slakter JS et al (1994) Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol 112:1057–1062CrossRefPubMedGoogle Scholar
  35. 35.
    Yavas GF, Kusbeci T, Kasikci M et al (2014) Obstructive sleep apnea in patients with central serous chorioretinopathy. Curr Eye Res 39(1):88–92CrossRefPubMedGoogle Scholar
  36. 36.
    Ratanasukon M, Bhurayanontachai P, Jirarattanasopa P (2012) High-dose antioxidants for central serous chorioretinopathy; the randomized placebo-controlled study. BMC Ophthalmol 12:20CrossRefPubMedCentralPubMedGoogle Scholar
  37. 37.
    Dean RT, Fu S, Stocker R et al (1997) Biochemistry and pathology of radical-mediated protein oxidation. Biochem J 324:1–18CrossRefPubMedCentralPubMedGoogle Scholar
  38. 38.
    Kundi H, Erel O, Balun A et al (2015) Association of thiol/disulfide ratio with syntax score in patients with NSTEMI. Scand Cardiovasc J 49:95–100CrossRefPubMedGoogle Scholar
  39. 39.
    Kundi H, Ates I, Kiziltunc E et al (2015) A novel oxidative stress marker in acute myocardial infarction; thiol/disulphide homeostasis. Am J Emerg Med 33(11):1567–1571CrossRefPubMedGoogle Scholar
  40. 40.
    Altiparmak IH, Erkus ME, Sezen H et al (2016) Evaluation of thiol levels, thiol/disulfide homeostasis and their relation with inflammation in cardiac syndrome X. Coron Artery Dis 27(4):295–301CrossRefPubMedGoogle Scholar
  41. 41.
    Turkoglu EB, Dikci S, Çelik E et al (2016) Thiol/disulfide homeostasis in patients with central serous chorioretinopathy. Curr Eye Res 22:1–3Google Scholar
  42. 42.
    Ziegler D (1985) Role of reversible oxidation-reduction of enzyme thiols-disulfides in metabolic regulation. Annu Rev Biochem 54:305–329CrossRefPubMedGoogle Scholar
  43. 43.
    Mccord JM (1993) Human disease, free radicals, and the oxidant/antioxidant balance. Clin Biochem 26:351–357CrossRefPubMedGoogle Scholar
  44. 44.
    Jiang S, Moriarty-Craige SE, Orr M et al (2005) Oxidant induced apoptosis in human retinal pigment epithelial cells: dependence on extracellular redox state. Invest Ophthalmol Vis Sci 46:1054–1061CrossRefPubMedGoogle Scholar
  45. 45.
    Dean O, Giorlando F, Berk M (2011) N-Acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action. J Psychiatry Neurosci 36:78–86CrossRefPubMedCentralPubMedGoogle Scholar
  46. 46.
    Hardy P, Abram D, Li DY et al (1994) Free radicals in retinal and choroidal blood flow autoregulation in the piglet: interaction with prostaglandins. Invest Ophthalmol Vis Sci 35:580–591PubMedGoogle Scholar
  47. 47.
    Szabo C, Thiemermann C, Vane JR (1993) Inhibition of the production of nitric oxide and vasodilator prostaglandins attenuates the cardiovascular response to bacterial endotoxin in adrenalectomized rats. Proc R Soc Lond B Biol Sci 11:233–238CrossRefGoogle Scholar
  48. 48.
    Beatty S, Koh H, Phil M et al (2000) The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45:115–134CrossRefPubMedGoogle Scholar
  49. 49.
    Ames BN, Shigenaga MK, Hagen TM et al (1993) Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci 90:7915–7922CrossRefPubMedCentralPubMedGoogle Scholar
  50. 50.
    Erel O (2004) A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 37:112–119CrossRefPubMedGoogle Scholar
  51. 51.
    Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38:1103–1111CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2017

Authors and Affiliations

  • Hasan Altinkaynak
    • 1
  • Piraye Zeynep Kurkcuoglu
    • 2
  • Mehtap Caglayan
    • 1
  • Mücella Arıkan Yorgun
    • 1
  • Nilay Yuksel
    • 1
  • Pınar Kosekahya
    • 4
  • Cemile Koca
    • 3
  • Yasin Toklu
    • 5
  1. 1.Department of OphthalmologyAnkara Atatürk Education and Research HospitalAnkaraTurkey
  2. 2.Department of OphthalmologyWorld Eye HospitalAnkaraTurkey
  3. 3.Department of BiochemistryYıldırım Beyazıt University, Ankara Atatürk Education and Research HospitalAnkaraTurkey
  4. 4.Ulucanlar Eye Education and Research HospitalAnkaraTurkey
  5. 5.Department of OphthalmologyYıldırım Beyazıt University, Ankara Atatürk Education and Research HospitalAnkaraTurkey

Personalised recommendations